PRFX

What one share of PRF Technologies holds

Pharmaceutical Preparations

We are a specialty pharmaceutical company focused on the reformulation of established therapeutics. Our proprietary extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates.

PRF Technologies’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.

Per-share figures
Sales$0.03
Profit−$7.47
Capex (buildings and equipment)$0.00
Free cash flow−$6.11
Cash and investments$3.76
Book value$10.29

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2022—−$63.46$0.04−$46.66——
2023$0.00−$122.94$0.12−$87.99——
2024$0.00−$105.52$0.09−$91.38——
2025$0.03−$7.47$0.00−$6.11—$10.29

Common questions about PRF Technologies

How much does one share of PRF Technologies earn?

Over its latest fiscal year, PRF Technologies lost $7.47 for each share on $0.03 of sales.

Does PRF Technologies pay a dividend?

PRF Technologies didn’t pay a dividend over its latest fiscal year, according to its SEC filings.

What is PRF Technologies’s book value per share?

PRF Technologies’s book value is $10.29 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.

How much cash and debt does each share of PRF Technologies have?

Each share of PRF Technologies has $3.76 of cash and investments, as of December 31, 2025.

What is PRF Technologies’s free cash flow per share?

−$6.11 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.

Has PRF Technologies bought back shares?

PRF Technologies’s share count rose about 368% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.